首页> 美国卫生研究院文献>Journal of Global Oncology >Pazopanib and Oral Cyclophosphamide in Women With Platinum-Resistant or -Refractory Epithelial Ovarian Cancer

【2h】

Pazopanib and Oral Cyclophosphamide in Women With Platinum-Resistant or -Refractory Epithelial Ovarian Cancer

机译：铂抗性或难治性上皮性卵巢癌女性的帕唑帕尼和口服环磷酰胺

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Women with recurrent, multiply-treated epithelial ovarian cancer (EOC) have unfavorable prognosis with limited treatment options after failure of platinum-based regimens. We report here a retrospective analysis of women with recurrent, platinum-resistant EOC treated with an oral regimen of pazopanib and cyclophosphamide.

机译：铂类疗法失败后，复发，接受多次治疗的上皮性卵巢癌（EOC）的妇女预后不良，治疗选择有限。我们在此报告对口服帕唑帕尼和环磷酰胺治疗的复发性铂耐药EOC妇女的回顾性分析。

著录项

期刊名称 Journal of Global Oncology
作者
Seema Gulia; Jaya Ghosh; Jyoti Bajpai; Sushmita Rath; Amita Maheshwari; T.S. Shylasree; Kedar Deodhar; Meenakshi Thakur; Sudeep Gupta;
展开▼
作者单位

展开▼
年(卷),期 2020(6),-1
年度 2020
页码 -1
总页数 6
原文格式 PDF
正文语种
中图分类肿瘤学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant,recurrent, pre-treated ovarian cancer - Results of the PACOVAR-trial [J] . Dinkic C., Eichbaum M., Schmidt M., Gynecologic Oncology: An International Journal . 2017 ,第2期

机译：Pazopanib（GW786034）和环磷酰胺在耐铂抗性，预处理的卵巢癌症患者中 - PACOVAR试验结果
2. The PACOVAR-trial: A phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancer [J] . Michael Eichbaum, Christine Mayer, Regina Eickhoff, BMC Cancer . 2011 ,第1期

机译：PACOVAR试验：帕唑帕尼（GW786034）和环磷酰胺在铂耐药的复发性预处理卵巢癌患者中的I / II期研究
3. Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer [J] . Noonan Anne M., Bunch Kristen P., Chen Jin-Qiu, Cancer: A Journal of the American Cancer Society . 2016 ,第4期

机译：SMAC模拟birinapant的2期研究在复发的铂耐药或难治性上皮性卵巢癌女性中的药效学标志物和临床结果
4. The Comparison of Glycosphingolipids in an Epithelial Ovarian Cancer Cell Line and a Nontumorigenic Epithelial Ovarian Cell Line using MALDI-MS [C] . Krishani K. Rajanayake, William R. Taylor, Dragan Isailovic ASMS Conference on Mass Spectrometry and Allied Topics . 2016

机译：使用MALDI-MS对上皮性卵巢癌细胞系中糖磷脂和非致素上皮性卵巢细胞系的比较
5. E3 Ligase Identified by Differential Display (EDD) Enhances Cell Survival and Cisplatin Resistance in Epithelial Ovarian Cancer and Oral Squamous Cell Carcinoma. [D] . Bradley, Amber Thompson. 2014

机译：通过差异显示（EDD）鉴定的E3连接酶可增强上皮性卵巢癌和口腔鳞状细胞癌的细胞存活率和顺铂耐药性。
6. The PACOVAR-trial: A phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent pre-treated ovarian cancer [O] . Michael Eichbaum, Christine Mayer, Regina Eickhoff, 2011

机译：PACOVAR试验：帕唑帕尼（GW786034）和环磷酰胺在铂耐药的复发性预处理卵巢癌患者中的I / II期研究
7. The PACOVAR-trial: A phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancer [O] . Michael Eichbaum, Christine Mayer, Regina Eickhoff, 2011

机译：PACOVAR试验：帕唑帕尼（GW786034）和环磷酰胺在铂耐药的复发性预处理卵巢癌患者中的I / II期研究

Pazopanib and Oral Cyclophosphamide in Women With Platinum-Resistant or -Refractory Epithelial Ovarian Cancer

摘要

著录项

相似文献

相关主题

期刊订阅